Report Detail
Global Pertuzumab Biosimilars Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
- RnM4572511 |
- 02 January, 2024 |
- Global |
- 94 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Pertuzumab Biosimilars market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
Pertuzumab is a recombinant humanized monoclonal antibody targeting HER2
The Global Info Research report includes an overview of the development of the Pertuzumab Biosimilars industry chain, the market status of Hospital (Human Pertuzumab, Animal Source Pertuzumab), Clinic (Human Pertuzumab, Animal Source Pertuzumab), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pertuzumab Biosimilars.
Regionally, the report analyzes the Pertuzumab Biosimilars markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pertuzumab Biosimilars market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pertuzumab Biosimilars market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pertuzumab Biosimilars industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Human Pertuzumab, Animal Source Pertuzumab).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pertuzumab Biosimilars market.
Regional Analysis: The report involves examining the Pertuzumab Biosimilars market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pertuzumab Biosimilars market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pertuzumab Biosimilars:
Company Analysis: Report covers individual Pertuzumab Biosimilars manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pertuzumab Biosimilars This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Pertuzumab Biosimilars. It assesses the current state, advancements, and potential future developments in Pertuzumab Biosimilars areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pertuzumab Biosimilars market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pertuzumab Biosimilars market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Human Pertuzumab
Animal Source Pertuzumab
Market segment by Application
Hospital
Clinic
Major players covered
Qilu Pharmaceutical
Zhengda Tianqing Company
Shanghai Henlius Biotech
CinnaGen
EDEN Biologics
NeuClone
Serum Institute of India
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pertuzumab Biosimilars product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pertuzumab Biosimilars, with price, sales, revenue and global market share of Pertuzumab Biosimilars from 2018 to 2023.
Chapter 3, the Pertuzumab Biosimilars competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pertuzumab Biosimilars breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Pertuzumab Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pertuzumab Biosimilars.
Chapter 14 and 15, to describe Pertuzumab Biosimilars sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Pertuzumab Biosimilars
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Pertuzumab Biosimilars Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Human Pertuzumab
- 1.3.3 Animal Source Pertuzumab
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Pertuzumab Biosimilars Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.5 Global Pertuzumab Biosimilars Market Size & Forecast
- 1.5.1 Global Pertuzumab Biosimilars Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Pertuzumab Biosimilars Sales Quantity (2018-2029)
- 1.5.3 Global Pertuzumab Biosimilars Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Qilu Pharmaceutical
- 2.1.1 Qilu Pharmaceutical Details
- 2.1.2 Qilu Pharmaceutical Major Business
- 2.1.3 Qilu Pharmaceutical Pertuzumab Biosimilars Product and Services
- 2.1.4 Qilu Pharmaceutical Pertuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Qilu Pharmaceutical Recent Developments/Updates
- 2.2 Zhengda Tianqing Company
- 2.2.1 Zhengda Tianqing Company Details
- 2.2.2 Zhengda Tianqing Company Major Business
- 2.2.3 Zhengda Tianqing Company Pertuzumab Biosimilars Product and Services
- 2.2.4 Zhengda Tianqing Company Pertuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Zhengda Tianqing Company Recent Developments/Updates
- 2.3 Shanghai Henlius Biotech
- 2.3.1 Shanghai Henlius Biotech Details
- 2.3.2 Shanghai Henlius Biotech Major Business
- 2.3.3 Shanghai Henlius Biotech Pertuzumab Biosimilars Product and Services
- 2.3.4 Shanghai Henlius Biotech Pertuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Shanghai Henlius Biotech Recent Developments/Updates
- 2.4 CinnaGen
- 2.4.1 CinnaGen Details
- 2.4.2 CinnaGen Major Business
- 2.4.3 CinnaGen Pertuzumab Biosimilars Product and Services
- 2.4.4 CinnaGen Pertuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 CinnaGen Recent Developments/Updates
- 2.5 EDEN Biologics
- 2.5.1 EDEN Biologics Details
- 2.5.2 EDEN Biologics Major Business
- 2.5.3 EDEN Biologics Pertuzumab Biosimilars Product and Services
- 2.5.4 EDEN Biologics Pertuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 EDEN Biologics Recent Developments/Updates
- 2.6 NeuClone
- 2.6.1 NeuClone Details
- 2.6.2 NeuClone Major Business
- 2.6.3 NeuClone Pertuzumab Biosimilars Product and Services
- 2.6.4 NeuClone Pertuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 NeuClone Recent Developments/Updates
- 2.7 Serum Institute of India
- 2.7.1 Serum Institute of India Details
- 2.7.2 Serum Institute of India Major Business
- 2.7.3 Serum Institute of India Pertuzumab Biosimilars Product and Services
- 2.7.4 Serum Institute of India Pertuzumab Biosimilars Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Serum Institute of India Recent Developments/Updates
3 Competitive Environment: Pertuzumab Biosimilars by Manufacturer
- 3.1 Global Pertuzumab Biosimilars Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Pertuzumab Biosimilars Revenue by Manufacturer (2018-2023)
- 3.3 Global Pertuzumab Biosimilars Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Pertuzumab Biosimilars by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Pertuzumab Biosimilars Manufacturer Market Share in 2022
- 3.4.2 Top 6 Pertuzumab Biosimilars Manufacturer Market Share in 2022
- 3.5 Pertuzumab Biosimilars Market: Overall Company Footprint Analysis
- 3.5.1 Pertuzumab Biosimilars Market: Region Footprint
- 3.5.2 Pertuzumab Biosimilars Market: Company Product Type Footprint
- 3.5.3 Pertuzumab Biosimilars Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Pertuzumab Biosimilars Market Size by Region
- 4.1.1 Global Pertuzumab Biosimilars Sales Quantity by Region (2018-2029)
- 4.1.2 Global Pertuzumab Biosimilars Consumption Value by Region (2018-2029)
- 4.1.3 Global Pertuzumab Biosimilars Average Price by Region (2018-2029)
- 4.2 North America Pertuzumab Biosimilars Consumption Value (2018-2029)
- 4.3 Europe Pertuzumab Biosimilars Consumption Value (2018-2029)
- 4.4 Asia-Pacific Pertuzumab Biosimilars Consumption Value (2018-2029)
- 4.5 South America Pertuzumab Biosimilars Consumption Value (2018-2029)
- 4.6 Middle East and Africa Pertuzumab Biosimilars Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Pertuzumab Biosimilars Sales Quantity by Type (2018-2029)
- 5.2 Global Pertuzumab Biosimilars Consumption Value by Type (2018-2029)
- 5.3 Global Pertuzumab Biosimilars Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Pertuzumab Biosimilars Sales Quantity by Application (2018-2029)
- 6.2 Global Pertuzumab Biosimilars Consumption Value by Application (2018-2029)
- 6.3 Global Pertuzumab Biosimilars Average Price by Application (2018-2029)
7 North America
- 7.1 North America Pertuzumab Biosimilars Sales Quantity by Type (2018-2029)
- 7.2 North America Pertuzumab Biosimilars Sales Quantity by Application (2018-2029)
- 7.3 North America Pertuzumab Biosimilars Market Size by Country
- 7.3.1 North America Pertuzumab Biosimilars Sales Quantity by Country (2018-2029)
- 7.3.2 North America Pertuzumab Biosimilars Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Pertuzumab Biosimilars Sales Quantity by Type (2018-2029)
- 8.2 Europe Pertuzumab Biosimilars Sales Quantity by Application (2018-2029)
- 8.3 Europe Pertuzumab Biosimilars Market Size by Country
- 8.3.1 Europe Pertuzumab Biosimilars Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Pertuzumab Biosimilars Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Pertuzumab Biosimilars Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Pertuzumab Biosimilars Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Pertuzumab Biosimilars Market Size by Region
- 9.3.1 Asia-Pacific Pertuzumab Biosimilars Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Pertuzumab Biosimilars Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Pertuzumab Biosimilars Sales Quantity by Type (2018-2029)
- 10.2 South America Pertuzumab Biosimilars Sales Quantity by Application (2018-2029)
- 10.3 South America Pertuzumab Biosimilars Market Size by Country
- 10.3.1 South America Pertuzumab Biosimilars Sales Quantity by Country (2018-2029)
- 10.3.2 South America Pertuzumab Biosimilars Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Pertuzumab Biosimilars Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Pertuzumab Biosimilars Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Pertuzumab Biosimilars Market Size by Country
- 11.3.1 Middle East & Africa Pertuzumab Biosimilars Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Pertuzumab Biosimilars Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Pertuzumab Biosimilars Market Drivers
- 12.2 Pertuzumab Biosimilars Market Restraints
- 12.3 Pertuzumab Biosimilars Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Pertuzumab Biosimilars and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Pertuzumab Biosimilars
- 13.3 Pertuzumab Biosimilars Production Process
- 13.4 Pertuzumab Biosimilars Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Pertuzumab Biosimilars Typical Distributors
- 14.3 Pertuzumab Biosimilars Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pertuzumab Biosimilars. Industry analysis & Market Report on Pertuzumab Biosimilars is a syndicated market report, published as Global Pertuzumab Biosimilars Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Pertuzumab Biosimilars market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
